Eli Lilly spokesperson Michael Jamison said in a written comment that telehealth companies sued by the drug manufacturer threaten patient safety by falsely promoting supposedly personalized compounded tirzepatide and mislead consumers about the safety, clinical testing, and effectiveness of their compounded knockoffs. Meanwhile, Novo Nordisk has filed 130 lawsuits against entities engaged in unlawful marketing and sale of knockoff semaglutide drugs, said Liz Skrbkova, a spokesperson for the drugmaker
In return, the drug company might agree to offer a rebate say, $10 less on a $100 drug
Clinical trials have rigorously assessed the safety and efficacy of tirzepatide, specifically focusing on its impact on weight management and blood sugar levels
Ketones cross the blood-brain barrier, providing 70% of the brains fuel by day 2
David Lans, you will be given detailed instructions and for each treatment and how they each are administered